Skip to content
Home/Companies/MedTech/Pixium

Pixium

MedTech·France·Exited 2024·Held 10yr
Entry
2014
Hold
10yr
Exit
2024

Who owns Pixium?

Pixium is a French MedTech company, now owned by Science, which acquired it in 2024 from Seventure Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Health for Life Capital · 2014 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
Science Corporation
Exit Year
2024

More from Health for Life Capital

Other portfolio companies in the same fund.

Clinical Microbiomics
Active
Kainova Therapeutics
Kainova Therapeutics
Active
BiotechCanada· 2026
MaaT Pharma
MaaT Pharma
Active
BiotechFrance· 2026
Microbiotica
Microbiotica
Active
BiotechUK· 2026
Standing Ovation
Active
BiotechFrance· 2026
Sunrise
Sunrise
Active
MedTechBelgium· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Pixium?

Pixium is now owned by Science, which acquired it in 2024 from Seventure Partners.

When did Science acquire Pixium?

Science acquired Pixium in 2024, buying from Seventure Partners.

Who did Pixium sell to?

Seventure Partners sold Pixium to Science in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue